Aftermath
After an analyst downgrade, over the next month
A rating downgrade; entry at the next session's close. Below, the latest ones, each with what the stock did after its own past events of this kind. Updated .
The typical S&P 500 stock gained +1.20% over the next month after an analyst downgrade (half of them between -2.16% and +4.49%), against +0.82% on any day.
Latest analyst downgrades, last few sessions
| Entry | Stock | Up after past ones, 1 month | Middle half | Worst · best | |
|---|---|---|---|---|---|
| Oct 30 | WEN | Argus Research: Buy → Sell | 0 of 3 | -7.7% to -2.0% | -12% · -1% |
| Oct 29 | WHR | Stifel: Hold → Sell | — | ||
| Oct 28 | MRNA Moderna | William Blair: Outperform → Market Perform | — | ||
| Oct 26 | DECK Deckers Brands | Piper Sandler: Neutral → Underweight | 3 of 4 | +3.0% to +8.7% | -8% · +15% |
| Oct 26 | GL Globe Life | Piper Sandler: Overweight → Neutral | — | ||
| Oct 26 | NCLH Norwegian Cruise Line … | JP Morgan: Neutral → Underweight | 1 of 4 | -15.6% to -1.7% | -19% · +27% |
| Oct 26 | VLO Valero Energy | Freedom Broker: Hold → Sell | 4 of 4 | +3.5% to +11.5% | +3% · +13% |
Each row is one stock's latest event, with what that stock did the next month after its own past events of this kind (the past 5 years, from the close of the session each was known). We don't rank stocks on these records: in our backtests, how a stock did after its past events did not predict its next one, and across the S&P 500 no kind of event leaned up or down after its day. History, not a forecast. Not advice.